Researchers have identified natural killer cells as a potential therapeutic target for the treatment of neuropathic pain. The immune cells can selectively degenerate axons, allowing repair of damaged nerves.
In this NCTalks podcast, Lauren Pulling speaks to Irene Tracey to hear more about her talk on imaging perception and lessons from pain, analgesia and anesthesia.
Effects of gabapentin, pregabalin and gastroretentive gabapentin on simulated driving, daytime sedation and cognition
In this research article from Pain Management, researchers investigate the effects of pregabalin, gabapentin and gastroretentive gabapentin on simulated driving performance.
A preliminary study has revealed that a monoclonal antibody could prevent difficult-to-treat migraines in patients who have tried unsuccessfully to prevent them using other treatments.
Analysis of three studies looks at the role of octagam® for chronic inflammatory demyelinating polyneuropathy patients
Editor’s summary considering the effectiveness and tolerability of octagam in patients with chronic inflammatory demyelinating polyneuropathy.
The latest study assessing the drug erenumab has demonstrated promising results for migraine sufferers who failed to respond to prior treatments.
A collection of the biggest news to come out of the Society for Neuroscience’s annual meeting, Neuroscience 2017, as well as interviews with the researchers behind the science.
Key research from the conference highlights opioid addiction research.
This article focuses the choice of surgical treatment in an unoperated patient with clinically established trigeminal neuralgia.